Abstract
Malaria is a life‐threatening disease caused by one of the five species of Plasmodium, among which Plasmodium falciparum cause the deadliest form of the disease. Plasmodium species are dependent on a vertebrate host and a blood‐sucking insect vector to complete their life cycle. Plasmodium chitinases belonging to the GH18 family are secreted inside the mosquito midgut, during the ookinete stage of the parasite. Chitinases mediate the penetration of parasite through the peritrophic membrane, facilitating access to the gut epithelial layer. In this review, we describe Plasmodium chitinases with special emphasis on chitinases from P. falciparum and P. vivax, the representative examples of the short and long forms of this protein. In addition to the chitinase domain, chitinases belonging to the long form contain a pro‐domain and chitin‐binding domain. Amino acid sequence alignment of long and short form chitinase domains reveals multiple positions containing variant residues. A subset of these positions was found to be conserved or invariant within long or short forms, indicating the role of these positions in attributing form‐specific activity. The reported differences in affinities to allosamidin for P. vivax and P. falciparum were predicted to be due to different residues at two amino acid positions, resulting in altered interactions with the inhibitor. Understanding the role of these amino acids in Plasmodium chitinases will help us elucidate the mechanism of catalysis and the mode of inhibition, which will be the key for identification of potent inhibitors or antibodies demonstrating transmission‐blocking activity.
Keywords: allosamidin, Anopheles, chitinase, malaria, Plasmodium, transmission‐blocking
1. INTRODUCTION
The 2020 World malaria report by the World Health organization (WHO) indicates that there were 229 million cases of malaria reported in the year 2019 with 409,000 deaths worldwide, the predominant numbers of which were from the WHO African region. 1 P. falciparum was responsible for 99.7% of estimated malaria cases in the WHO African region, and P. vivax for 75% of malaria cases in the WHO Americas. 1 In India, P. falciparum and P. vivax infections contributed to 45.6% and 53.6% of the total estimated cases in the year 2019. 1 Plasmodium can be transmitted to humans by the bites of infected female Anopheles mosquitoes, many species of which have been identified as vectors of disease. Preventive vector control measures like insecticide treated nets (ITNs), 2 indoor residual spraying (IRS), 3 mosquito larval source management, 4 seasonal malaria chemoprevention (SMC) 5 and intermittent preventive treatment in pregnancy (IPTp) 6 in conjunction with rapid diagnostic tests (RDT) 7 and effective medications 1 , 8 has significantly brought down the incidence rate for many years. The emergence of pyrethroid resistance 9 in mosquitoes and artemisinin resistance 10 in parasites has increasingly become a cause of concern for the global community. Therefore, there is an unmet need to employ alternative strategies in combination with the existing methods for malaria elimination and eradication. The potential strategies include but not restricted to drug development against novel targets, 8 vaccine development, 11 , 12 and transmission‐blockade. 13 The aim of transmission‐blocking strategy is to target Plasmodium proteins in the mosquito stage, consequently blocking the development of parasite in the vector. 12 , 13 Plasmodium proteins expressed at different developmental stages inside mosquitoes have been identified as targets of transmission‐blockade. 12 Among the many identified targets, the parasite chitinase has an indispensable function inside the midgut of mosquitoes. 14 The secretion of chitinase by the ookinete stage of the parasite results in a cascade of events, leading to the development of oocysts. Loss of function studies validate Plasmodium chitinases as a promising transmission‐blocking candidate. 14 A carboxy‐terminal truncation of the Plasmodium falciparum chitinase (PfCHT1) significantly hampered oocyst development, but not gametogenesis, ex‐flagellation, and ookinete formation (the stages preceding the secretion of chitinase) in Anopheles freeborni midguts. 14 Knockout of Plasmodium berghei chitinase (PbCHT1) lowered its infectivity up to 90%, due to impairment in the development of oocysts. 15 Consequently, no ookinete derived chitinase activity was detected in vitro. 15 Addition of allosamidin, a chitinase inhibitor, in the blood meal completely hampered oocyst development in Plasmodium gallinaceum. 16 1C3, a murine monoclonal antibody neutralizing P. falciparum chitinase activity had transmission‐blocking activity in mosquitoes. 17 In this report, we review Plasmodium chitinases with a note on the long and short forms, attempting to understand the primary basis for the differences reported between them.
2. PLASMODIUM CHITINASES BELONG TO THE GH18 FAMILY OF HYDROLASES
Chitin, a long‐chain polymer of N‐acetyl glucosamine (NAG) is the second most abundant polysaccharide in nature. 18 Chitin can be found in three crystalline polymorphic forms–α, β, and γ, based on anti‐parallel and parallel arrangements of the chitin microfibrils. 18 α‐chitin, the most prevalent form of chitin, is found in fungal cell walls and the exoskeletons of insect and crustacean shells. 19 Chitin is degraded by chitinases (EC.3.2.1.14), which are glycosyl hydrolases (GH) acting on the β‐1,4‐linkages present between the NAG units. 20 Carbohydrate active enzyme database (CAZy) groups chitinases into GH families–18 and 19. 21 Chitinases from the GH18 family is prevalent among viruses, bacteria, fungi, plants, and animals; GH19 family among plants, bacteria (Chitinophaga spp.) 22 and nematodes (Globodera rostochiensis). 23 Studies on GH18 Chitinases have also revealed an important role for this enzyme in insect morphogenesis (Cecropia silk moth), 24 transmission of pathogens (Plasmodium spp.) 25 and vertebrate immune mechanism (Human macrophages). 26 Sequence and structural studies of Serratia marcescens chitinase indicated the existence of a signal peptide, serine–threonine linkers, insertion domain (α + β insertion domain) and multiple catalytic domains, which are also found in some other GH18 family of chitinases. 27 , 28 Further, some GH18 family chitinases also have zero to seven chitin‐binding domains 29 with zero to multiple fibronectin type III domains. 30 All these elements contribute to the diversity of class 18 family of chitinases.
Chitinases belonging to GH18 families have a triosephosphate isomerase (TIM) barrel structure (Figure 1(a),(b)). The TIM barrel fold is found in proteins with diverse functions, serving as a paradigm for one‐fold with many functions scaffold structure. 32 The TIM barrel structure consists of eight beta strands (β1–β8) tethered with eight alpha helices, characteristic of a TIM barrel framework. The catalytic and substrate binding signature motifs are highly conserved within the GH18 chitinase family (Figure 2). The signature motif, DXXDXDXE, proven to have potential role of catalysis, is mapped to the β4 sheet (PDB ID: 4AXN). 34 Plasmodium chitinases belong to the GH18 family with a TIM barrel structure (Figure 1(a),(b)) play a key role in the transmission of the malaria parasite in the mosquito stage of its life cycle.
FIGURE 1.
A ribbon representation of the TIM barrel fold from the predicted model structures of Chitinases from (a) Plasmodium falciparum and (b) Plasmodium vivax prepared by PyMOL. TIM Barrel is an eight stranded α‐β fold with β sheets forming a barrel (black), surrounded by α helices. Plasmodium falciparum chitinase contains a single catalytic domain (depicted in green and black comprising of α helices and β sheets, respectively). In Plasmodium vivax, the pro‐domain (red) and Chitin binding domain (orange) flanks the catalytic domain. (c) depicts the domain architecture of Plasmodium chitinases. Short form (PfCHT1, PgCHT2, PrCHT1, PreCHT2) and Long forms (PvCHT1, PgCHT1, PbCHT1, PreCHT1) of Plasmodium chitinases are annotated at the catalytic domain and chitin binding domains as reported elsewhere. 31 The signal sequence ranges from 1–20 (observed in the long form) to 1–31/32 residues (observed in PgCHT2, a representative of short form). Long form of chitinases harbor pro‐domain, catalytic domain, and chitin binding domain. Pro‐domain although not annotated in most cases, is found to be located at the N‐terminal end of the catalytic domain in PvCHT1 and PbCHT1. Represented chitinases are PgCHT1 and PgCHT2: Plasmodium gallinaceum chitinase, PfCHT1: Plasmodium falciparum chitinase, PvCHT1: Plasmodium vivax chitinase, PbCHT1: Plasmodium berghei chitinase, PrCHT1: Plasmodium reichenowei chitinase, PreCHT1 and PreCHT2: Plasmodium relictum chitinase
FIGURE 2.
Sequence alignment of Plasmodium chitinases using T‐Coffee and shaded with Box shade method. The long [L] and short [S] forms are indicated in parenthesis. Substrate binding site and catalytic binding sites are labeled accordingly. The residues predicted to interact with allosamidin are boxed and highlighted using asterisk (*). The catalytic site contains a position (marked as +) in which either Tyr or Trp present in short or long forms, defines the pH optimum. 33 Represented chitinases are PgCHT1 and PgCHT2: Plasmodium gallinaceum chitinase, PfCHT1: Plasmodium falciparum chitinase, PvCHT1: Plasmodium vivax chitinase, PbCHT1: Plasmodium berghei chitinase, PrCHT1: Plasmodium reichenowei chitinase, PreCHT1 and PreCHT2: Plasmodium relictum chitinases. Although, P. knowlesi, P. chabaudi and P. yoelii chitinases have not been included in the sequence alignment, the same trend with sequence conservation is observed at the indicated positions
3. OOKINETES EXPRESS CHITINASE TO PENETRATE THE PERITROPHIC MEMBRANE
Plasmodium parasites have a complex lifecycle comprised of sexual and asexual stages inside the vector and vertebrate host, respectively. Mosquitoes transfer the mature sporozoites to vertebrate hosts through a blood bite, which culminates with sporozoites undergoing gametogenesis. Mosquitoes ingest the male and female gametocytes along with blood, which upon entering the gut, form the zygote. 35 Zygotes undergo further developmental changes to result in the formation of motile, elongated ookinetes, 36 which secrete chitinases to breakdown chitin fibrils and consequently penetrate the peritrophic membrane. 37
Distention of the mosquito midgut post‐ingestion of the blood signals the formation of a chitinous peritrophic membrane. 38 In Anopheles stephensi, the apical secretory vesicles of midgut epithelial cells secrete type I Peritrophic membrane (PM), which appears 12 h after blood meal and matures at the end of 48 h. 39 , 40 In Anopheles gambiae, the PM is synthesized de novo and attains maximum thickness by the end of 24 h, post‐ blood meal ingestion. PM is reported to be composed of chitin (NAG), although in A. stephensi, galactose is reported to be present along with N‐acetyl galactosamine. 41 Proteins present in the PM called peritropins, contain 2,3 or 4 chitin‐binding domains, have been proposed to cross‐link the chitin fibrils. 42 PM envelopes the food bolus and is speculated to prevent or reduce pathogen invasion (and therefore the reason why parasite secretes chitinase), facilitate digestion of blood, and protect the midgut epithelial cells from abrasion or chemical damage. 43
The first evidence for the existence of Plasmodium chitinase was from an electron micrograph of P. gallinaceum ookinete, showcasing electron dense material at the apical end of ookinete, around which the PM appeared disrupted. 44 P. gallinaceum and P. falciparum chitinases, PgCHT1 and PfCHT1 are expressed inside the micronemes and are later accumulated at the apical end of the ookinete. 44 Expression of PgCHT1 is observed 10 h post‐ ex‐flagellation, and by 24 h, expression is seen throughout the cytoplasm of mature ookinetes. 16 Chitinase from P. gallinaceum (PgCHT1) is produced as a partially active or inactive zymogen, which later gets activated by the proteases in the mosquito midgut. 45 P. vivax and P. berghei ookinetes secrete chitinase as a zymogen and therefore are like PgCHT1. 15 , 46 On the other hand, P. falciparum ookinetes secrete chitinase (PfCHT1) as an enzymatically active form. The localisation of trypsin within the PM validates the dependency of PgCHT1 on proteases in P. gallinaceum. 25 , 47 Addition of a serine protease inhibitor, 16 leupeptin or anti‐trypsin antisera was found to block the activation of PfCHT1 and transmission of the parasite. 47 , 48 It is speculated that PfCHT1 is an ortholog of the P. gallinaceum short form chitinase, PgCHT2. 31 After the chitin layer is breached, the ookinetes reach the basal lamina and develop to form the oocysts harboring sporozoites. Upon rupture of oocysts, the sporozoites travel to the salivary gland and enter the vertebrate host following a mosquito bite. Therefore, dissolution of the peritrophic membrane is an essential step facilitated by chitinases secreted by Plasmodium. 49
4. PROPERTIES OF PLASMODIUM CHITINASES
Chitinases from Plasmodium species have been reported to exist in two different forms, long form, and a short form. Phylogenetic analysis predicts P. gallinaceum chitinases to be the ancestor of Plasmodium chitinases present in species specifically infecting mammals. While both forms of chitinases have been identified in P. gallinaceum, either short form or the long form has been annotated for P. falciparum and P. vivax, respectively. P. vivax chitinase contains pro‐domain, chitin‐binding and catalytic domains, whereas P. falciparum chitinase contains only the catalytic domain (Figure 1(c)). Further, studies with other species of Plasmodium (P. knowlesi, P. chabaudi, P. yoelii, P. reichenowi) indicated that possibly these Plasmodium spp. subsequently lost the short or long forms, the evolutionary advantage of which is still unclear. 31 , 50 Characterisation of PvCHT1, PgCHT1, PreCHT1 (P. relictum chitinase) and PbCHT1 (P. berghei chitinase) indicated that long forms of chitinases are expressed as catalytically inactive forms, 16 which subsequently gets activated within the mosquito midgut by proteases. 50 , 51 In fact, a dual lysine repeat (KK) present at the junction of the catalytic domain, 42 amino acids from the N‐terminal end of PgCHT1 (and corresponding position in PvCHT1, PgCHT1, and PbCHT1) can be a plausible cleavage site for trypsin. In A. gambiae chitinase, a 13‐mer peptide derived from a putative pro‐domain region was demonstrated to inhibit both A. gambiae and P. falciparum chitinases. 52 Chitin‐binding domains are carbohydrate binding modules, typically found in multi‐domain proteins along with other domains. There are three types of Carbohydrate‐binding modules (CBM)–Type A, B, and C. Type A binds to chitin and other polysaccharides, which is further classified into CBM1, CBM2, CBM3, CBM5, and CBM10. 53 Although, CBM2, CBM3, and CBM5 were shown to have chitin‐binding properties, only CBM5 is found in chitinases. Mutational analysis on chitin binding domains of Bacillus circulans and Streptomyces griseus chitinases highlighted the importance of this domain in substrate specificity and catalysis. 54 , 55
Experimental analysis using varying lengths of the substrate, NAG, showed that recombinant P. falciparum chitinase (rPfCHT1) efficiently processes polymers containing 3, 4, or 5 units of NAG. 46 Likewise, rPvCHT1 was also demonstrated to hydrolyse chitotrioside containing 4‐methylumbelliferone (4‐MU‐GlcNAc3), 46 indicating that PfCHT1 and PvCHT1 are endochitinases, like PgCHT1. 46 Maximal activity was observed at pH 4.5 and pH 7.0– 8.0 for rPfCHT1 and rPvCHT1, respectively. 46 Site‐directed mutagenesis of the catalytic residue, Trp291, present in between Asp290 and Glu292 at the active site (numbering with respect to PvCHT1), to Tyr in Manduca sexta chitinase (a long form chitinase belonging to the GH18 family) resulted in a decrease in the pH optimum by one unit. 33 Plant chitinases derived from Hevea brasiliensis and Cycas revoluta have a pH optimum of 4.0 – 5.0 and Tyr residue at this position. 56 , 57 Sequence analysis of the long and short forms of chitinases clearly showed that Trp291 is conserved in the long form, whereas Tyr291 (Residue numbering of PvCHT1) was present in the short form of chitinases (Figure 2), inferring the importance of this amino acid in conferring optimum pH. Whether this observation can be extrapolated to other chitinases needs to be ascertained. Knowledge about amino acids that can change the pH optima of chitinases has potential industrial applications. Optimal temperature for activity was found to be 40°C and 35°C for rPfCHT1 and rPvCHT1, respectively, at pH 8.0. The specific activities of purified rPfCHT1 and rPvCHT1 were 2070 x 103 and 7313 units, respectively, 46 where each unit for specific activity of recombinant chitinases was defined as fluorescence units per min per mg of protein using 4MU‐GlcNAc3 as a substrate. There appears to be a correlation between the long form of chitinases containing the chitin‐binding domain and low specific activities, exemplified by the P. vivax chitinase. Whether this correlation is observed in other chitinases needs to be determined. It will be interesting to understand the reason as to why the long forms are secreted as inactive zymogens and the short forms are secreted as catalytically active forms. Possibly the presence of chitin‐binding domains along with the secretion of inactive forms, introduces a spatio‐temporal regulation for the long forms of chitinases. This regulation is dialed out in short forms along probably compensated with high specific activity. A recent report showed that PgCHT2 and its ortholog PfCHT1 form high‐molecular weight (HMW) complexes, the implications of which are unknown. 58
Sequence alignment of four representative long forms (PvCHT1, PbCHT1, PreCHT1, and PgCHT1) or four short forms (PgCHT2, PfCHT1, PrCHT1, and PreCHT2), lead to the construction of a consensus‐like signature sequence for the long and short forms. When the consensus sequence belonging to the long and short forms were aligned, some of the positions were not invariant (Figure 3). For example, the position 283, immediately preceding the catalytic site, contains Gly (nonpolar residue) in the short form and Asp (negatively charged residue) in the long form (Figure 2). Although, the reason behind form‐specific conservation of amino acid residues at certain positions are not clearly understood, its plausible role in defining the properties of long or short forms cannot be undermined. Amino acid residue differences at some of these positions highlighted in Figure 3, could possibly lead to an alteration in the specific activity of chitinases. Parallel to this observation, pH optimum can be partly attributed to a Trp or Tyr at position 291 (labeled as + in Figure 2).
FIGURE 3.
Comparison of the consensus amino acid sequences of the long and short forms of Plasmodium chitinases. The individual consensus sequence for long and short forms were derived by sequence alignment of chitinases from four species each (the sequences of which are compared in Figure 2). At the positions displayed in the figure, differences in amino acids were observed. For example, position 283 contains Gly (nonpolar residue) in the short and Asp (negatively charged residue) in the long form. + indicates the predicted residue position involved in binding to allosamidin. Residue numbering is with respect to PvCHT1
5. INHIBITION OF PLASMODIUM CHITINASES WITH ALLOSAMIDIN
Allosamidin, a pseudo‐trisaccharide isolated from the mycelium of Streptomyces species is a potent inhibitor of chitinases. 59 The prevalence of oocysts was significantly decreased when allosamidin was fed along with the blood meal containing P. gallinaceum and P. falciparum gametocytes to Aedes aegypti and Anopheles freeborni, respectively. 45 The addition of exogenous chitinase or polyoxin D, an inhibitor of chitin synthase, to the blood meal alleviated the allosamidin‐mediated inhibition of oocyst development, 60 validating the target of allosamidin as chitinase. The inhibitory concentration (IC50) for allosamidin against PfCHT1 and PgCHT2 (short forms) was in the range of 1 – 300 nM, 46 whereas against PvCHT1 and PgCHT1 (long forms) was in the range of 6 – 12 μM. 46 In the absence of structural information, the reason behind this differential inhibition of allosamidin of P. vivax and P. falciparum/gallinaceum chitinases is not clear.
Homology modeling of chitinases from P. vivax and P. falciparum using Phyre 2 , 61 generated a structure containing the expected (α/β)8 TIM barrel backbone with the catalytic and substrate‐binding sites mapped onto β4 and β3 sheets, respectively. Predictive structural modeling studies of PfCHT1 and PvCHT1 with allosamidin performed using AutoDock 4.2 62 showed that Glu259 and Thr260 (numbering with reference to PvCHT1) are involved in polar hydrogen bonding interactions with –OH of tetrahydro‐4H‐cyclopenta[d]oxazole and –CH2OH of the middle glucose ring of allosamidin, respectively (Figure 4). Lys410 in PfCHT1 is involved in a hydrogen bonding interaction with ‐OH of the terminal glucose ring of allosamidin. This interaction is not possible in PvCHT1 with a valine residue at the same position. In PfCHT1, an amide moiety substituted on the middle glucose ring of allosamidin is likely to fit optimally in the binding pocket due to the presence of the comparatively smaller and less bulky residue, Ser472. Owing to the presence of a slightly bulkier residue like His at this position in PvCHT1, the substituted amide on the middle glucose ring of allosamidin might not fit optimally in PvCHT1. Therefore, out of the four residues predicted to bind to allosamidin, residues at two positions (410 and 472) were not conserved between PfCHT1 and PvCHT1, possibly the reason behind differential sensitivity to allosamidin (Figures 2 and 3). When the other sequences of short and long forms were analyzed, the following trend was observed: Lys or His, and Val or Leu were present at 410th position in the short and long forms, respectively; Ser and His were present at 472nd position in the short and long forms, respectively (displayed as * and boxed in Figure 2). Whether allosamidin exhibits low and high binding affinities to all the long and short forms of chitinases from different Plasmodium spp., needs to be experimentally determined.
FIGURE 4.
Prediction on binding mode of allosamidin with PfCHT1. (a) Two‐dimensional structural representation of allosamidin (C25H42N4O14). (b) Representation of binding mode of allosamidin to Plasmodium falciparum chitinase showing conserved residues – Glu259 and Thr260 forming polar hydrogen bonding interactions with –OH of tetrahydro‐4H‐cyclopenta[d]oxazole. Unlike His472 in PvCHT1, Ser472 in PfCHT1 orients the amide moiety of allosamidin for optimal interaction. Lys410 (Pf) interacts with the terminal glucose ring in allosamidin whereas His472 and Val410 of Plasmodium vivax (Pv) chitinase fails to make polar interactions. Residue numbering is with respect to PvCHT1
6. SUMMARY
Transmission‐blocking strategies aim to inhibit parasite development inside the mosquito host by targeting parasite proteins. Inside the midgut of the mosquitos, the parasite secretes chitinases belonging to the GH18 hydrolase family to degrade the peritrophic membrane and invade the epithelial layer. Different species of Plasmodium secrete chitinases either as a catalytically active form as in Plasmodium falciparum (short form) and/or as a partially active or inactive zymogen, as in Plasmodium vivax (long form). P. gallinaceum has both forms with the evolutionary descendants retaining either one form or the other. P. falciparum chitinase exhibits ~283‐fold and ~1000‐fold differences in specific activity and sensitivity to allosamidin, respectively, as compared to its P. vivax counterpart. The observed differences could be due to changes in the amino acid residues mapped at specific positions not restricted to the catalytic and substrate‐binding sites (Figure 3). Plasmodium chitinases can serve as a paradigm to study the sequence–structure–function correlation of proteins and therefore it will be interesting to perform mutational and structural studies to understand the role of amino acid positions exhibiting form‐specific conservation in the long and short forms. Further, this understanding can facilitate the design of inhibitors or selection of epitopes for antibodies with transmission‐blocking activity.
CONFLICT OF INTEREST
All authors have no conflicts of interest to declare relevant to this study.
AUTHOR CONTRIBUTIONS
Vysakh K. Viswanath: Data curation; writing‐original draft; writing‐review & editing. Suraj T. Gore: Investigation. Ashwathi Valiyaparambil: Data curation; writing‐original draft. Subhendu Mukherjee: Investigation. Anirudha Lakshminarasimhan: Supervision; writing‐review & editing.
ACKNOWLEDGMENTS
This work was supported by Tata Institute for Genetics and Society, India. We thank Dr Suresh Subramani, Global director, TIGS, for reviewing the manuscript.
Viswanath VK, Gore ST, Valiyaparambil A, Mukherjee S, Lakshminarasimhan A. Plasmodium chitinases: revisiting a target of transmission‐blockade against malaria. Protein Science. 2021;30:1493–1501. 10.1002/pro.4095
REFERENCES
- 1. Who.int, 2021 . World malaria report 2020. https://www.who.int/publications/i/item/9789240015791.
- 2. Pryce J, Richardson M, Lengeler C. Insecticide‐treated nets for preventing malaria. Cochrane Database Syst Rev. 2018;11:CD000363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Choi L, Pryce J, Garner P. Indoor residual spraying for preventing malaria in communities using insecticide‐treated nets. Cochrane Database Syst Rev. 2019;5:CD012688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Majambere S, Jawara M, Conway D, et al. Is mosquito larval source management appropriate for reducing malaria in areas of extensive flooding in The Gambia? A cross‐over intervention trial. Am J Trop Med Hygiene. 2010;82:176–184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Coldiron M, Von Seidlein L, Grais R. Seasonal malaria chemoprevention: successes and missed opportunities. Malar J. 2017;16:481–485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Gosling R, Cairns M, Chico R, Chandramohan D. Intermittent preventive treatment against malaria: an update. Expert Rev Anti‐Infective Therapy. 2010;8:589–606. [DOI] [PubMed] [Google Scholar]
- 7. McMorrow M, Aidoo M, Kachur S. Malaria rapid diagnostic tests in elimination settings—can they find the last parasite? Clin Microbiol Infect. 2011;17:1624–1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Kumar S, Bhardwaj T, Prasad D, Singh R. Drug targets for resistant malaria: historic to future perspectives. Biomed Pharmacother. 2018;104:8–27. [DOI] [PubMed] [Google Scholar]
- 9. Liu N, Xu Q, Zhu F, Zhang L. Pyrethroid resistance in mosquitoes. Insect Sci. 2006;13:159–166. [Google Scholar]
- 10. Dondorp A, Yeung S, White L, et al. Artemisinin resistance: Current status and scenarios for containment. Nat Rev Microbiol. 2006;8:272–280. [DOI] [PubMed] [Google Scholar]
- 11. Duffy P, Gorres J. Malaria vaccines since 2000: progress, priorities, products. npj Vaccines. 2020;5:48. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Saul A. Mosquito stage, transmission blocking vaccines for malaria. Curr Opin Infect Dis. 2007;20:476–481. [DOI] [PubMed] [Google Scholar]
- 13. Delves M, Angrisano F, Blagborough A. Antimalarial transmission‐blocking interventions: past, present, and future. Trends Parasitol. 2018;34:735–746. [DOI] [PubMed] [Google Scholar]
- 14. Tsai Y, Hayward R, Langer R, Fidock D, Vinetz J. Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut. Infect Immun. 2001;69:4048–4054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Dessens J, Mendoza J, Claudianos C, et al. Knockout of the rodent malaria parasite chitinase PbCHT1 reduces infectivity to mosquitoes. Infect Immun. 2001;69:4041–4047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Vinetz J, Valenzuela J, Specht C, et al. Chitinases of the avian malaria parasite Plasmodium gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut. J Biol Chem. 2000;275:10331–10341. [DOI] [PubMed] [Google Scholar]
- 17. Langer R, Li F, Popov V, Kurosky A, Vinetz J. Monoclonal antibody against the Plasmodium falciparum chitinase, PfCHT1, recognizes a malaria transmission‐blocking epitope in Plasmodium gallinaceum ookinetes unrelated to the chitinase PgCHT1. Infect Immun. 2002;70:1581–1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Rudall K, Kenchington W. The chitin system. Biol Rev. 1973;48:597–633. [Google Scholar]
- 19. Jang M, Kong B, Jeong Y, Lee C, Nah J. Physicochemical characterization of α‐chitin, β‐chitin, and γ‐chitin separated from natural resources. J Polym Sci A. 2004;42:3423–3432. [Google Scholar]
- 20. Oyeleye Y, Normi M. Chitinase: diversity, limitations, and trends in engineering for suitable applications. Biosci Rep. 2018;38:BSR2018032300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Lombard V, Golaconda Ramulu H, Drula E, Coutinho P, Henrissat B. The carbohydrate‐active enzymes database (CAZy) in 2013. Nucleic Acids Res. 2013;42:D490–D495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Sangkhobol V, Skerman V. Chitinophaga, a new genus of chitinolytic myxobacteria. Int J Syst Bacteriol. 1981;31:285–293. [Google Scholar]
- 23. Abbasi K, Zafari D, Wick R. Evaluation of chitinase enzyme in fungal isolates obtained from golden potato cyst nematode (Globodera rostochiensis). Zemdirbyste‐Agricult. 2017;104:179–184. [Google Scholar]
- 24. Janet BY, Passonneau V, Williams CM. The moulting fluid of the cecropia silkworm. J Exp Biol. 1953;30:545–560. [Google Scholar]
- 25. Huber M, Cabib E, Miller L. Malaria parasite chitinase and penetration of the mosquito peritrophic membrane. Proc Natl Acad Sci U S A. 1991;88:2807–2810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Zhu Z. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL‐13 pathway activation. Science. 2004;304:1678–1682. [DOI] [PubMed] [Google Scholar]
- 27. Huang Q, Xie X, Liang G, et al. The GH18 family of chitinases: Their domain architectures, functions and evolutions. Glycobiology. 2011;22:23–34. [DOI] [PubMed] [Google Scholar]
- 28. Van Aalten D, Synstad B, Brurberg M, et al. Structure of a two‐domain chitotriosidase from Serratia marcescens at 1.9‐a resolution. Proc Natl Acad Sci U S A. 2000;97:5842–5847. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Karlsson M, Stenlid J. Evolution of family 18 glycoside hydrolases: diversity, domain structures and phylogenetic relationships. J Mol Microbiol Biotechnol. 2008;16:208–223. [DOI] [PubMed] [Google Scholar]
- 30. Toratani T, Kezuka Y, Nonaka T, Hiragi Y, Watanabe T. Structure of full‐length bacterial chitinase containing two fibronectin type III domains revealed by small angle X‐ray scattering. Biochem Biophys Res Commun. 2006;348:814–818. [DOI] [PubMed] [Google Scholar]
- 31. Li F, Patra K, Vinetz J. An anti‐chitinase malaria transmission–blocking single‐chain antibody as an effector molecule for creating a Plasmodium falciparum–refractory mosquito. J Infect Dis. 2005;192:878–887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Nagano N, Orengo C, Thornton J. One‐fold with many functions: the evolutionary relationships between TIM barrel families based on their sequences, structures and functions. J Mol Biol. 2002;321:741–765. [DOI] [PubMed] [Google Scholar]
- 33. Lu Zen K, Muthukrishnan S, Kramer K. Site‐directed mutagenesis and functional analysis of active site acidic amino acid residues D142, D144 and E146 in Manduca sexta (tobacco hornworm) chitinase. Insect Biochem Mol Biol. 2002;32:1369–1382. [DOI] [PubMed] [Google Scholar]
- 34. Payne C, Baban J, Horn S, et al. Hallmarks of processivity in glycoside hydrolases from crystallographic and computational studies of the Serratia marcescens chitinases. J Biol Chem. 2012;287:36322–36330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Vaughan A, Aly A, Kappe S. Malaria parasite pre‐erythrocytic stage infection: gliding and hiding. Cell Host Microbe. 2008;4:209–218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Janse C, Mons B, Rouwenhorst R, et al. In‐vitro formation of ookinetes and functional maturity of Plasmodium berghei gametocytes. Parasitology. 1985;91:19–29. [DOI] [PubMed] [Google Scholar]
- 37. Alavi Y, Arai M, Mendoza J, et al. The dynamics of interactions between Plasmodium and the mosquito: a study of the infectivity of Plasmodium berghei and Plasmodium gallinaceum, and their transmission by Anopheles stephensi, Anopheles gambiae and Aedes aegypti . Int J Parasitol. 2003;33:933–943. [DOI] [PubMed] [Google Scholar]
- 38. Peters W. Functions of peritrophic membranes. Zoophysiology. 1992;30:149–210. [Google Scholar]
- 39. Berner R, Rudin W, Hecker H. Peritrophic membranes and protease activity in the midgut of the malaria mosquito, Anopheles stephensi (Liston) (Insecta: Diptera) under normal and experimental conditions. J Ultrastruct Res. 1983;83:195–204. [DOI] [PubMed] [Google Scholar]
- 40. Ponnudurai T, Billingsley P, Rudin W. Differential infectivity of Plasmodium for mosquitoes. Parasitol Today. 1988;4:319–321. [DOI] [PubMed] [Google Scholar]
- 41. Wilkins S, Billingsley P. Partial characterization of oligosaccharides expressed on midgut microvillar glycoproteins of the mosquito, Anopheles stephensi Liston. Insect Biochem Mol Biol. 2001;31:937–948. [DOI] [PubMed] [Google Scholar]
- 42. Shao L, Devenport M, Jacobs‐Lorena M. The peritrophic matrix of hematophagous insects. Arch Insect Biochem Physiol. 2001;47:119–125. [DOI] [PubMed] [Google Scholar]
- 43. Hegedus D, Erlandson M, Gillott C, Toprak U. New insights into peritrophic matrix synthesis, architecture, and function. Annu Rev Entomol. 2009;54:285–302. [DOI] [PubMed] [Google Scholar]
- 44. Langer R, Hayward R, Tsuboi T, Tachibana M, Torii M, Vinetz J. Micronemal transport of Plasmodium ookinete chitinases to the electron‐dense area of the apical complex for extracellular secretion. Infect Immun. 2000;68:6461–6465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Shahabuddin M, Toyoshima T, Aikawa M, Kaslow D. Transmission‐blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease. Proc Natl Acad Sci U S A. 1993;90:4266–4270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Takeo S, Hisamori D, Matsuda S, Vinetz J, Sattabongkot J, Tsuboi T. Enzymatic characterization of the Plasmodium vivax chitinase, a potential malaria transmission‐blocking target. Parasitol Int. 2009;58:243–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Shahabuddin M. Plasmodium ookinete development in the mosquito midgut: a case of reciprocal manipulation. Parasitology. 1998;116:S83–S93. [DOI] [PubMed] [Google Scholar]
- 48. Shahabuddin M, Criscio M, Kaslow D. Unique specificity of in vitro inhibition of mosquito midgut trypsin‐like activity correlates with in vivo inhibition of malaria parasite infectivity. Exp Parasitol. 1995;80:212–219. [DOI] [PubMed] [Google Scholar]
- 49. Han Y. Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes. EMBO J. 2000;19:6030–6040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Waters A, Higgins D, McCutchan T. Plasmodium falciparum appears to have arisen as a result of lateral transfer between avian and human hosts. Proc Natl Acad Sci U S A. 1991;88:3140–3144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Sieber K, Huber M, Kaslow D, et al. The peritrophic membrane as a barrier: its penetration by Plasmodium gallinaceum and the effect of a monoclonal antibody to ookinetes. Experim Parasitol. 1991;72:145–156. [DOI] [PubMed] [Google Scholar]
- 52. Bhatnagar R, Arora N, Sachidanand S, Shahabuddin M, et al. Synthetic propeptide inhibits mosquito midgut chitinase and blocks sporogonic development of malaria parasite. Biochem Biophys Res Commun. 2003;304:783–787. [DOI] [PubMed] [Google Scholar]
- 53. Shoseyov O, Shani Z, Levy I. Carbohydrate binding modules: biochemical properties and novel applications. Microbiol Mol Biol Rev. 2006;70:283–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Uni F, Lee S, Yatsunami R, Fukui T, Nakamura S. Mutational analysis of a CBM family 5 chitin‐binding domain of an alkaline chitinase from Bacillus sp. J813. Biosci Biotechnol Biochem. 2012;76:530–535. [DOI] [PubMed] [Google Scholar]
- 55. Itoh Y, Kawase T, Nikaidou N, et al. Functional analysis of the chitin‐binding domain of a family 19 chitinase from Streptomyces griseus HUT 6037: substrate‐binding affinity and cis‐dominant increase of antifungal function. Biosci Biotechnol Biochem. 2002;66:1084–1092. [DOI] [PubMed] [Google Scholar]
- 56. Terwisscha van Scheltinga A, Armand S, Kalk K, Isogai A, Henrissat B, Dijkstra B. Stereochemistry of chitin hydrolysis by a plant chitinase/lysozyme and x‐ray structure of a complex with allosamidin evidence for substrate assisted catalysis. Biochemistry. 1995;34:15619–15623. [DOI] [PubMed] [Google Scholar]
- 57. Taira T, Hayashi H, Tajiri Y, et al. A plant class V chitinase from a cycad (Cycas revoluta): biochemical characterization, cDNA isolation, and posttranslational modification. Glycobiology. 2009;19:1452–1461. [DOI] [PubMed] [Google Scholar]
- 58. Patra K, Kaur H, Kolli SK, et al. A hetero‐multimeric chitinase‐containing Plasmodium falciparum and Plasmodium gallinaceum ookinete‐secreted protein complex involved in mosquito midgut invasion. Front Cell Infect Microbiol. 2021;10:846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Huang G. Chitinase inhibitor allosamidin and its analogues: an update. Curr Organ Chem. 2012;16:115–120. [Google Scholar]
- 60. Shahabuddin M, Kaidoh T, Aikawa M, Kaslow D. Plasmodium gallinaceum: mosquito peritrophic matrix and the parasite‐vector compatibility. Exp Parasitol. 1995;81:386–393. [DOI] [PubMed] [Google Scholar]
- 61. Kelley L, Mezulis S, Yates C, Wass M, Sternberg M. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845–858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Morris G, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30:2785–2791. [DOI] [PMC free article] [PubMed] [Google Scholar]